Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Vet. Sci.

Sec. Veterinary Infectious Diseases

Volume 12 - 2025 | doi: 10.3389/fvets.2025.1692395

Isolation and Characterization of Canine Adenovirus Type 2 (CAV-HN45) and Its Selective Infection of Human Cervical Cancer Cells with Preliminary Oncolytic Potential

Provisionally accepted
Congrong  WangCongrong Wang1Dong-Mei  WangDong-Mei Wang2Guo-You  YinGuo-You Yin2Yan-Hong  WangYan-Hong Wang2Min  LuMin Lu2Zhuo-Wei  ZhangZhuo-Wei Zhang2Yue  WenYue Wen2Ding-Zhuo  GaoDing-Zhuo Gao2Jun  HongJun Hong2Peng-Fei  FuPeng-Fei Fu2*
  • 1Henan University of Urban Construction, Pingdingshan, China
  • 2College of Life Science and Engineering, Henan University of Urban Construction, Pingdingshan, China

The final, formatted version of the article will be published soon.

Canine adenovirus type 2 (CAdV-2) infects the respiratory tissues of dogs and induces canine infectious laryngotracheitis. CAdV-2 has a high incidence of infection and is easily co-infected with other viruses. Moreover, CAdV-2 is a mammalian adenovirus with characteristics similar to those of Human Adenovirus Type 5 (HAdV-5), making it a promising candidate for recombinant vaccine development and gene therapy applications. In this study, we isolated and identified a CAdV-2 strain (CAV-HN45) and investigated its growth characteristics and viral tropism by evaluating its infection efficiency in various cell lines. Our findings demonstrate that CAV-HN45 can effectively infect cells of swine, canine, and human origin. In vitro, CAV-HN45 efficiently infected HeLa cells and showed selective infectivity toward human cervical cancer cells, although replication capacity declined after serial passages. This study provides a reference for the future studies on adenovirus vaccine vectors with high selective expression, potentially offering promising applications in the treatment of human cancers.

Keywords: Canine adenovirus 2, Isolation, characterization, phylogeny, infection spectrum, Oncolytic potential

Received: 25 Aug 2025; Accepted: 07 Oct 2025.

Copyright: © 2025 Wang, Wang, Yin, Wang, Lu, Zhang, Wen, Gao, Hong and Fu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Peng-Fei Fu, fpfwdm@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.